MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-GA-02-0002518
Medizest Pharmaceuticals Private Limited - pharma in Verna, Goa, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.59 Cr
▲ 54% YoY
Net loss · FY 2024
₹2.77 Cr
Net margin -13.5%
EBITDA · FY 2024
₹1.19 Cr
EBITDA margin 5.8%
Authorised capital
₹4.6 Cr
Registered with MCA
Paid-up capital
₹4.03 Cr
Issued & subscribed
Open charges
₹1.73 Cr
Satisfied ₹22.5 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
70
Provident fund records
About Medizest Pharmaceuticals Private Limited
Data last updated:
Medizest Pharmaceuticals Private Limited is a private limited company based in Verna, Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24232GA1987PTC007465. Its GSTIN is 30AAACK7535M1ZI (Goa).
The company has an authorised share capital of ₹4.6 Cr and a paid-up capital of ₹4.03 Cr. It was formerly known as Kare Labs Private Limited. It is led by directors including Anurag Agrawal (Managing Director) and Krishnakumar Gangadhar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – 40 Verna Industrial Estate Salcete, Goa, India – 403722.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.59 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net loss of ₹2.77 Cr (net margin -13.5%) and EBITDA of ₹1.19 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 14% over five years.
The company has about 70 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.73 Cr and satisfied charges of ₹22.5 Cr on record. Court records list 67 cases involving the company, including 9 filed by the company and 60 filed against it; 3 cases are pending.
Medizest Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GA-02-0002518). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agrawalgroupgoa.com.
Company details
CIN U24232GA1987PTC007465
Registration Number 007465
Incorporation Date 30 June 1987
ROC Goa
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GA-02-0002518
CIN history
Medizest Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232GA1987PTC007465, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232GA1987PTC007465 | Current |
| U24232MH1987PTC188182 | Previous |
| U24232GA1987PTC000759 | Previous |
Key People
Anurag Agrawal Managing Director Krishnakumar Gangadhar Agrawal Director Anirudh Krishnakumar Agrawal Director Recognitions & Rankings of Medizest Pharmaceuticals
Contact details
Medizest Pharmaceuticals Private Limited's registered office is in Verna, Goa. Its website is agrawalgroupgoa.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressL – 40 Verna Industrial Estate Salcete, Goa, India – 403722
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medizest Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medizest Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medizest Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medizest Pharmaceuticals Private Limited, buy the company report.
Financials of Medizest Pharmaceuticals Private Limited
FY 2025 filings availableMedizest Pharmaceuticals Private Limited reported revenue of ₹20.59 Cr (up 54% YoY) for FY 2024.
Revenue · FY 2024
₹20.59 Cr ▲ 54%
Net loss · FY 2024
₹2.77 Cr margin -13.5%
EBITDA · FY 2024
₹1.19 Cr margin 5.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 12%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 266%
3 years · compounded
▲ 45%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 54% growth in the latest year. EBITDA rose 266% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.77 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | -13.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medizest Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medizest Pharmaceuticals Private Limited
Medizest Pharmaceuticals has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnakumar Gangadhar Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Agrawal Medicaments Private Limited and 5 more | Director | 04 Aug 2011 | 15 Years 3 Months | Current |
| Anirudh Krishnakumar Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Agrawal Medicaments Private Limited and 5 more | Director | 04 Aug 2011 | 15 Years 3 Months | Current |
| Anurag Agrawal Also directs: Agrawal Minerals (Goa) Private Limited, Aryavaan Pharmaceuticals Private Limited, Agrawal Medicaments Private Limited and 5 more | Managing Director | 04 Aug 2011 | 15 Years 3 Months | Current |
| Navinchandra Dinker Sheldenkar | Director | 04 Apr 2025 | 1 Years 7 Months | Current |
Peer comparison
Medizest Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kesar Pharma Limited | ₹20.63 Cr (FY 2025) | -26.0% | Gandhinagar, Gujarat, India | |||
| Dewcare Concept Private Limited | ₹20.61 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Bda Health Care Private Limited | ₹20.61 Cr (FY 2025) | 1.0% | Parshivani, Maharashtra, India | |||
| Medizest Pharmaceuticals Private Limitedthis company | ₹20.59 Cr (FY 2024) | -₹2.77 Cr | -13.5% | 54.0% | 70 | Verna, Goa, India |
| Reflux Pharmaceuticals Private Limited | ₹20.56 Cr (FY 2025) | 15.0% | Thane, Maharashtra, India | |||
| Morvin India Health Care Private Limited | ₹20.53 Cr (FY 2025) | 14.0% | Sanand, Gujarat, India | |||
| Neomediispecs Private Limited | ₹20.5 Cr (FY 2025) | -24.0% | Chennai, Tamil Nadu, India | |||
| Apollo Ingredients India Private Limited | ₹20.45 Cr (FY 2024) | -30.0% | Thane, Maharashtra, India |
To see the full peer comparison of Medizest Pharmaceuticals Private Limited, buy the company report.
Auditor
Medizest Pharmaceuticals Private Limited is audited by H. K. APARANJI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H. K. APARANJI | FY 2023 | 000199S |
Shareholding
The shareholding of Medizest Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medizest Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.73 Cr
Satisfied charges
₹22.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2014 | 10628473 | Others | ₹1.5 Cr | Open | |
| 30 Apr 1997 | 90077210 | Goa Urban Co-0P. Bank | ₹23 Lakh | Open | |
| 09 Feb 2017 | 100091563 | Others | ₹85 Lakh | Satisfied | |
| 26 Nov 2009 | 10192377 | Idbi Bank Limited | ₹10 Cr | Satisfied | |
| 27 Nov 2006 | 10031815 | Small Industries Development Bank of India | ₹25 Lakh | Satisfied |
To see the full charge records of Medizest Pharmaceuticals Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Medizest Pharmaceuticals Private Limited has 67 court cases on record: 9 filed by Medizest Pharmaceuticals, 60 filed against it. 3 cases are pending and 64 are disposed.
Total cases
67
Filed by the company
9
Filed against the company
60
Pending
3
Disposed
64
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 52 | 49 | 2 |
| High courts | 15 | 11 | 1 |
Cases on record (5 of 67)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by M/S. Emkay Pharma Pvt. Ltd. | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against Ms Well Worth Medicines Private Limited | Disposed |
| District court, Valsad, Gujarat | Court case (SPCS) | Filed against the company by M/S.Well Worth Medicines Private Ltd | Disposed |
| Bombay High Court | Appeal | Filed against the company by M/S. Kare Labs Pvt. Ltd. | Disposed |
| Bombay High Court | Appeal | Filed by the company against M/S. Kare Labs Pvt. Ltd. | Disposed |
To see the full case history of Medizest Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Medizest Pharmaceuticals Private Limited has 6 MSME Form 1 returns on record between 2021 and 2023, listing 212 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mahal Plastics and Fibres Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Herald Publications Pvt. Ltd. | |||
| an individual supplier |
To see the full MSME payment records of Medizest Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Medizest Pharmaceuticals Private Limited has a workforce of 70 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
70
Active EPFO establishments
1
Employee growth
25%
GST
Medizest Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAACK7535M1ZI | Goa | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medizest Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medizest Pharmaceuticals Private Limited has 13 board changes on record since 2007: 4 appointments and 9 cessations. The latest: Navinchandra Dinker Sheldenkar ceased to be Additional Director on 29 Sep 2025.
AGM
Medizest Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Navinchandra Dinker Sheldenkar ceased to be Additional Director.
Charges
A charge with Others of Rs. 1.50 Cr registered on 28 Nov 2014 with Charge ID 10628473 was modified on 05 Jun 2025.
Appointed
Navinchandra Dinker Sheldenkar was appointed as Director.
Filing
Medizest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa.
Charges
A charge registered on 09 Feb 2017 via Charge ID 100091563 with Others was fully satisfied on 14 Mar 2024.
Ceased
Anurag Agrawal ceased to be Director.
Charges
A charge registered on 04 Nov 2004 via Charge ID 90075817 with Edc Limited was fully satisfied on 29 May 2020.
Ceased
Maya Krishnakumar Agrawal ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.85 Cr with Charge ID 100091563 was registered on 09 Feb 2017.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 10628473 was registered on 28 Nov 2014.
Charges
A charge with Edc Limited of Rs. 8.00 Cr registered on 04 Nov 2004 with Charge ID 90075817 was modified on 18 Sep 2014.
26 earlier events are in the company report.
Frequently asked questions
Medizest Pharmaceuticals is an active private limited company based in Verna, Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 1987 (39+ years old) and is registered under CIN U24232GA1987PTC007465.
Medizest Pharmaceuticals has 4 current directors:
- Anurag Agrawal - Managing Director
- Krishnakumar Gangadhar Agrawal - Director
- Anirudh Krishnakumar Agrawal - Director
- Navinchandra Dinker Sheldenkar - Director
The latest financial statements of Medizest Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medizest Pharmaceuticals is 30AAACK7535M1ZI, registered in Goa.
The CIN (Corporate Identification Number) of Medizest Pharmaceuticals is U24232GA1987PTC007465. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medizest Pharmaceuticals has 67 court cases on record: 9 filed by the company and 60 filed against it. 3 are pending. Most are in the district courts.
Medizest Pharmaceuticals was incorporated on 30 June 1987, making it 39+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Medizest Pharmaceuticals by revenue are Kesar Pharma Limited, Dewcare Concept Private Limited, Bda Health Care Private Limited, Reflux Pharmaceuticals Private Limited, Morvin India Health Care Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Navinchandra Dinker Sheldenkar ceased to be Additional Director on 29 Sep 2025. Navinchandra Dinker Sheldenkar was appointed as Director on 04 Apr 2025. Anurag Agrawal ceased to be Director on 01 Apr 2022. Medizest Pharmaceuticals has 13 board changes on record in total.
Yes, Medizest Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GA-02-0002518).
Medizest Pharmaceuticals has 6 MSME Form 1 returns on record between 2021 and 2023, listing 212 overdue payments to 15 micro and small suppliers. The latest return was filed on 05 Dec 2023.
Medizest Pharmaceuticals can be reached through the website agrawalgroupgoa.com. Its registered office is in Verna, Goa, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages